BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 18076478)

  • 1. Effects of sphingosine-1-phosphate and sphingosylphosphorylcholine on intracellular Ca2+ and cell death in prostate cancer cell lines.
    Mulders AC; Nau S; Li Y; Michel MC
    Auton Autacoid Pharmacol; 2007 Oct; 27(4):173-9. PubMed ID: 18076478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of contractile mechanisms of sphingosylphosphorylcholine and sphingosine-1-phosphate in rabbit coronary artery.
    Choi SK; Ahn DS; Lee YH
    Cardiovasc Res; 2009 May; 82(2):324-32. PubMed ID: 19218288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lysophospholipids increase interleukin-8 expression in ovarian cancer cells.
    Schwartz BM; Hong G; Morrison BH; Wu W; Baudhuin LM; Xiao YJ; Mok SC; Xu Y
    Gynecol Oncol; 2001 May; 81(2):291-300. PubMed ID: 11330965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of lysophospholipids on signaling in the human Jurkat T cell line.
    Xu Y; Casey G; Mills GB
    J Cell Physiol; 1995 Jun; 163(3):441-50. PubMed ID: 7775587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingosylphosphorylcholine and sphingosine-1-phosphate mobilize cytosolic calcium through different mechanisms in human airway epithelial cells.
    Orlati S; Porcelli AM; Hrelia S; Rugolo M
    Cell Calcium; 1998 Jun; 23(6):387-94. PubMed ID: 9924630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of intracellular sphingosine-1-phosphate production by inositol 1,4,5-trisphosphate-evoked calcium mobilisation in HEK-293 cells: endogenous sphingosine-1-phosphate as a modulator of the calcium response.
    Blom T; Slotte JP; Pitson SM; Törnquist K
    Cell Signal; 2005 Jul; 17(7):827-36. PubMed ID: 15763425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signal transduction underlying the vascular effects of sphingosine 1-phosphate and sphingosylphosphorylcholine.
    Hemmings DG
    Naunyn Schmiedebergs Arch Pharmacol; 2006 Apr; 373(1):18-29. PubMed ID: 16570136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative measurement of sphingosine 1-phosphate by radioreceptor-binding assay.
    Murata N; Sato K; Kon J; Tomura H; Okajima F
    Anal Biochem; 2000 Jun; 282(1):115-20. PubMed ID: 10860507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sphingosylphosphorylcholine stimulates human monocyte-derived dendritic cell chemotaxis.
    Lee HY; Shin EH; Bae YS
    Acta Pharmacol Sin; 2006 Oct; 27(10):1359-66. PubMed ID: 17007744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The multi-functional role of sphingosylphosphorylcholine.
    Nixon GF; Mathieson FA; Hunter I
    Prog Lipid Res; 2008 Jan; 47(1):62-75. PubMed ID: 18042469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sphingosylphosphorylcholine enhances calcium entry in thyroid FRO cells by a mechanism dependent on protein kinase C.
    Afrasiabi E; Blom T; Ekokoski E; Tuominen RK; Törnquist K
    Cell Signal; 2006 Oct; 18(10):1671-8. PubMed ID: 16490345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sphingosine-1-phosphate (S1P) is a novel fibrotic mediator in the eye.
    Swaney JS; Moreno KM; Gentile AM; Sabbadini RA; Stoller GL
    Exp Eye Res; 2008 Oct; 87(4):367-75. PubMed ID: 18687328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sphingolipids differentially regulate mitogen-activated protein kinases and intracellular Ca2+ in vascular smooth muscle: effects on CREB activation.
    Mathieson FA; Nixon GF
    Br J Pharmacol; 2006 Feb; 147(4):351-9. PubMed ID: 16402047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sphingosylphosphorylcholine as a novel calmodulin inhibitor.
    Kovacs E; Liliom K
    Biochem J; 2008 Mar; 410(2):427-37. PubMed ID: 17979830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ca2+ signaling induced by sphingosylphosphorylcholine and sphingosine 1-phosphate via distinct mechanisms in rat glomerular mesangial cells.
    Chen PF; Chin TY; Chueh SH
    Kidney Int; 1998 Nov; 54(5):1470-83. PubMed ID: 9844123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of sphingosine kinase 1 and S1P receptors in chemotherapy-resistant prostate cancer PC3 cells and their camptothecin-induced up-regulation.
    Akao Y; Banno Y; Nakagawa Y; Hasegawa N; Kim TJ; Murate T; Igarashi Y; Nozawa Y
    Biochem Biophys Res Commun; 2006 Apr; 342(4):1284-90. PubMed ID: 16516161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sphingosine 1-phosphate induces Mcl-1 upregulation and protects multiple myeloma cells against apoptosis.
    Li QF; Wu CT; Guo Q; Wang H; Wang LS
    Biochem Biophys Res Commun; 2008 Jun; 371(1):159-62. PubMed ID: 18423379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel neurotrophic effects of sphingosylphosphorylcholine in cerebellar granule neurons and in PC12 cells.
    Konno N; Nakamura A; Ikeno Y; Cheon SH; Kitamoto K; Arioka M
    Biochem Biophys Res Commun; 2007 Dec; 364(1):163-8. PubMed ID: 17935698
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel clusters of receptors for sphingosine-1-phosphate, sphingosylphosphorylcholine, and (lyso)-phosphatidic acid: new receptors for "old" ligands.
    Kostenis E
    J Cell Biochem; 2004 Aug; 92(5):923-36. PubMed ID: 15258916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia enhances sphingosine kinase 2 activity and provokes sphingosine-1-phosphate-mediated chemoresistance in A549 lung cancer cells.
    Schnitzer SE; Weigert A; Zhou J; Brüne B
    Mol Cancer Res; 2009 Mar; 7(3):393-401. PubMed ID: 19240180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.